- Home
- PLAY vs IOVA Comparison
PLAY vs IOVA Comparison
Compare PLAY & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLAY
- IOVA
- Stock Information
- Founded
- PLAY 1982
- IOVA 2007
- Country
- PLAY United States
- IOVA United States
- Employees
- PLAY N/A
- IOVA N/A
- Industry
- PLAY Restaurants
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PLAY Consumer Discretionary
- IOVA Health Care
- Exchange
- PLAY Nasdaq
- IOVA Nasdaq
- Market Cap
- PLAY 887.6M
- IOVA 975.1M
- IPO Year
- PLAY 1995
- IOVA N/A
- Fundamental
- Price
- PLAY $16.00
- IOVA $2.47
- Analyst Decision
- PLAY Hold
- IOVA Buy
- Analyst Count
- PLAY 8
- IOVA 12
- Target Price
- PLAY $27.43
- IOVA $10.36
- AVG Volume (30 Days)
- PLAY 1.5M
- IOVA 20.9M
- Earning Date
- PLAY 12-09-2025
- IOVA 11-06-2025
- Dividend Yield
- PLAY N/A
- IOVA N/A
- EPS Growth
- PLAY N/A
- IOVA N/A
- EPS
- PLAY 0.26
- IOVA N/A
- Revenue
- PLAY $2,112,500,000.00
- IOVA $250,425,000.00
- Revenue This Year
- PLAY $2.83
- IOVA $65.15
- Revenue Next Year
- PLAY $5.65
- IOVA $58.47
- P/E Ratio
- PLAY $61.90
- IOVA N/A
- Revenue Growth
- PLAY N/A
- IOVA 175.62
- 52 Week Low
- PLAY $13.04
- IOVA $1.64
- 52 Week High
- PLAY $40.10
- IOVA $9.70
- Technical
- Relative Strength Index (RSI)
- PLAY 54.08
- IOVA 57.23
- Support Level
- PLAY $13.04
- IOVA $2.09
- Resistance Level
- PLAY $15.23
- IOVA $2.55
- Average True Range (ATR)
- PLAY 0.96
- IOVA 0.24
- MACD
- PLAY 0.28
- IOVA 0.01
- Stochastic Oscillator
- PLAY 99.25
- IOVA 61.59
About PLAY Dave & Buster's Entertainment Inc.
Dave & Buster's Entertainment Inc owns and operates nearly a hundred entertainment and dining establishments in the United States where customers can eat, drink, play games, and watch televised sports. Each store offers a full menu of entries and appetizers, a complete selection of alcoholic and non-alcoholic beverages, and an extensive assortment of entertainment attractions centered around playing games and watching live sports and other televised events. It derives maximum revenue from Entertainment.
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.